semaglutide vs tirzepatide weight loss studies semaglutide: A new battle in obesity treatment Comparative safety and side effects

Recently, the Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN) 6 and Researching Cardiovascular Events with a Weekly Incretin in Diabetes trials have shown that therapy with glucagon-like peptide-1 receptor agonists (GLP-1RAs) decreases the risk of cardiovascular events in high-risk patients with T2DM [6, 7]

In addition, cross-sectional dietary analyses suggest that GLP-1RA therapy can reduce nutrient intake in ways that may affect protein and micronutrient sufficiency [75]

y.PahlM

Because of that, it won't necessarily be as quick of a fix for your skin issues as other powerhouses but that doesn't mean it's not an effective one

GLP-1 analogues did not increase the risk for pancreatic cancer when compared to the control OR 1.06